Medscape is available in 5 Language Editions – Choose your Edition here.


Delusions of Parasitosis

  • Author: Noah S Scheinfeld, JD, MD, FAAD; Chief Editor: Dirk M Elston, MD  more...
Updated: Jan 20, 2016


Delusions of parasitosis (DoP) manifest in the patient's firm belief that he or she has pruritus due to an infestation with insects. Patients may present with clothing lint, pieces of skin, or other debris contained in plastic wrap, on adhesive tape, or in matchboxes. They typically state that these contain the parasites; however, these collections have no insects or parasites. This presentation is called the matchbox sign, or what the authors term the "Saran-wrap sign."

The patients have no obvious cognitive impairment, and abnormal organic factors are absent. True infestations and primary systemic diseases that cause pruritus are not involved. Primary skin lesions are not present. Physical examination may reveal no lesions, but only linear erosions with crusts, prurigo nodularis, and/or ulcers.

The classification of delusions of parasitosis is complicated. It is considered primarily a monosymptomatic hypochondriacal psychosis and has been associated with schizophrenia, obsessional states, bipolar disorder, depression, and anxiety disorders. Delusions of parasitosis occur primarily in white middle-aged or older women, although the condition has been reported in all age groups and in men.

Savely et al[1] introduced the term Morgellon disease to describe a condition characterized by fibers attached to the skin. The entity appears to be little more than a new designation for delusions of parasitosis. Koblenzer[2] and Waddell and Burke[3] have discussed the utility of the term, with Murase et al[4] finding the term useful for building a therapeutic alliance with patients with delusions of parasitosis. The Centers for Disease Control and Prevention is currently investigating Morgellon disease.[5]

William Harvey[6] of the Morgellons Research Foundation Medical Advisory Board states the following:

"All patients with Morgellons carry elevated laboratory proinflammatory markers, elevated insulin levels, and verifiable serologic evidence of 3 bacterial pathogens. They also show easily found physical markers such as peripheral neuropathy, delayed capillary refill, abnormal Romberg’s sign, decreased body temperature, and tachycardia. Most importantly they will improve, and most recover on antibiotics directed at the above pathogens."

The author of this article has not found reliable data to back up William Harvey's claims, but they are included here to comprehensively address this issue.

Walling and Swick[7] suggest abandoning 3 the diagnostic terms trichotillomania, delusions of parasitosis, and neurotic excoriation, which they believe have become barriers to treatment. Instead, they suggest using the alternative patient-centered nomenclature of neuromechanical alopecia, pseudoparasitic dysesthesia, and (simply) excoriation.

It is important to note that many patients with psychopathology complain of delusions of parasitosis, but the coexistence of delusions of parasitosis and another condition, the author thinks, is independent of pure delusions of parasitosis without other symptoms.[8, 9]

One study of 47 patients reported that those noting bugs appeared to be more likely to be diagnosed with of delusional disorder or to have a medical diagnosis, as opposed to those noting fibers, who were more likely deemed to possess a somatoform disorder. Patients referred to a medical setting for delusions of parasitosis were 300 times more likely to require a physician to engage the hospital's legal counsel versus other patients in the same clinical setting.[10]

European researchers reported a series of 148 delusions of parasitosis patients. None of the patients possessed genuine infestation, as was shown by thorough examinations. Thirty-five percent of the patients believed themselves to be parasite infested. Most patients in this series noted a significant number of other living or inanimate (17%) pathogenic agents. Seventy-one (48%) of the 148 patients presented to doctors with “proof” of their infestations. These specimens were, for the most part, skin bits or hair and rarely insects. Only a few of these insects were anthropophilic or of human pathogenicity. No insects could be linked to the clinical presentations.[11]

Two comprehensive reviews in 2013 reiterated the necessity for clinicians to establish a therapeutic alliance with patients due to the challenges of treating a condition that a clinician might think is psychological in nature while the patient is convinced it is real and physical.[12, 13]

To help the patient a strong theraputic alliance must be established with the patient.[14]



The cause of delusions of parasitosis is unknown. It appears related to neurochemical pathology. This concept is underlined by its induction by psychoactive agents (eg, amphetamines, cocaine, and methylphenidate) and its coincidence with depression, schizophrenia, social isolation, and sensory impairment. Some reports have linked delusions of parasitosis to hyperthyroidism, which was deemed a secondary type of delusions of parasitosis, because it resolved with pimozide therapy and thyroid medications.




The exact prevalence of delusions of parasitosis is unknown.


The literature includes one report of suicide in a 40-year-old man with delusions of parasitosis.[15]

Race-, sex-, and age-related demographics

Delusions of parasitosis appear to be more common in whites than in people of other races.

Delusions of parasitosis occur primarily in white middle-aged or older women, although the condition has been reported in all age groups and in men. The female-to-male ratio is approximately 2:1. More specifically, this ratio is 1:1 in people younger than 50 years and 3:1 in those older than 50 years.[16, 17]


Contributor Information and Disclosures

Noah S Scheinfeld, JD, MD, FAAD Assistant Clinical Professor, Department of Dermatology, Weil Cornell Medical College; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Assistant Attending Dermatologist, New York Presbyterian Hospital; Assistant Attending Dermatologist, Lenox Hill Hospital, North Shore-LIJ Health System; Private Practice

Noah S Scheinfeld, JD, MD, FAAD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Abbvie<br/>Received income in an amount equal to or greater than $250 from: Optigenex<br/>Received salary from Optigenex for employment.

Specialty Editor Board

David F Butler, MD Section Chief of Dermatology, Central Texas Veterans Healthcare System; Professor of Dermatology, Texas A&M University College of Medicine; Founding Chair, Department of Dermatology, Scott and White Clinic

David F Butler, MD is a member of the following medical societies: American Medical Association, Alpha Omega Alpha, Association of Military Dermatologists, American Academy of Dermatology, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Phi Beta Kappa

Disclosure: Nothing to disclose.

Jeffrey Meffert, MD Associate Clinical Professor of Dermatology, University of Texas School of Medicine at San Antonio

Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Additional Contributors

Franklin Flowers, MD Department of Dermatology, Professor Emeritus Affiliate Associate Professor of Pathology, University of Florida College of Medicine

Franklin Flowers, MD is a member of the following medical societies: American College of Mohs Surgery

Disclosure: Nothing to disclose.

  1. Savely VR, Leitao MM, Stricker RB. The mystery of Morgellons disease: infection or delusion?. Am J Clin Dermatol. 2006. 7(1):1-5. [Medline].

  2. Koblenzer CS. The challenge of Morgellons disease. J Am Acad Dermatol. 2006 Nov. 55(5):920-2. [Medline].

  3. Waddell AG, Burke WA. Morgellons disease?. J Am Acad Dermatol. 2006 Nov. 55(5):914-5. [Medline].

  4. Murase JE, Wu JJ, Koo J. Morgellons disease: a rapport-enhancing term for delusions of parasitosis. J Am Acad Dermatol. 2006 Nov. 55(5):913-4. [Medline].

  5. Marris E. Mysterious 'Morgellons disease' prompts US investigation. Nat Med. 2006 Sep. 12(9):982. [Medline].

  6. Harvey WT. Morgellons disease. J Am Acad Dermatol. 2007 Apr. 56(4):705-6. [Medline].

  7. Walling HW, Swick BL. Psychocutaneous syndromes: a call for revised nomenclature. Clin Exp Dermatol. 2007 May. 32(3):317-9. [Medline].

  8. Hylwa SA, Foster AA, Bury JE, Davis MD, Pittelkow MR, Bostwick JM. Delusional infestation is typically comorbid with other psychiatric diagnoses: review of 54 patients receiving psychiatric evaluation at Mayo Clinic. Psychosomatics. 2012 May. 53(3):258-65. [Medline].

  9. Fellner MJ. New findings in delusions of parasitosis. Skinmed. 2012 Mar-Apr. 10(2):72-4. [Medline].

  10. Reichenberg JS, Magid M, Jesser CA, Hall CS. Patients labeled with delusions of parasitosis compose a heterogenous group: a retrospective study from a referral center. J Am Acad Dermatol. 2013 Jan. 68(1):41-6, 46.e1-2. [Medline].

  11. Freudenmann RW, Lepping P, Huber M, et al. Delusional infestation and the specimen sign: a European multicentre study in 148 consecutive cases. Br J Dermatol. 2012 Aug. 167(2):247-51. [Medline].

  12. Levin EC, Gieler U. Delusions of parasitosis. Semin Cutan Med Surg. 2013 Jun. 32(2):73-7. [Medline].

  13. Heller MM, Wong JW, Lee ES, Ladizinski B, Grau M, Howard JL, et al. Delusional infestations: clinical presentation, diagnosis and treatment. Int J Dermatol. 2013 Jul. 52(7):775-83. [Medline].

  14. Patel V, Koo JY. Delusions of parasitosis; suggested dialogue between dermatologist and patient. J Dermatolog Treat. 2015 Oct. 26(5):456-60. [Medline].

  15. Monk BE, Rao YJ. Delusions of parasitosis with fatal outcome. Clin Exp Dermatol. 1994 Jul. 19(4):341-2. [Medline].

  16. Aw DC, Thong JY, Chan HL. Delusional parasitosis: case series of 8 patients and review of the literature. Ann Acad Med Singapore. 2004 Jan. 33(1):89-94. [Medline].

  17. Bouree P, Benattar B, Perivier S. [Ekbom syndrome or delusional parasitosis]. Rev Prat. 2007 Mar 31. 57(6):585-9. [Medline].

  18. Goddard J. Seasonality of delusions of parasitosis. J Agromedicine. 2003. 9(1):23-6. [Medline].

  19. Vila-Rodriguez F, Macewan BG. Delusional parasitosis facilitated by web-based dissemination. Am J Psychiatry. 2008 Dec. 165(12):1612. [Medline].

  20. Edison KE, Slaughter JR, Hall RD. Psychogenic parasitosis: a therapeutic challenge. Mo Med. 2007 Mar-Apr. 104(2):132-7; quiz 137-8. [Medline].

  21. Le L, Gonski PN. Delusional parasitosis mimicking cutaneous infestation in elderly patients. Med J Aust. 2003 Aug 18. 179(4):209-10. [Medline].

  22. Bury JE, Bostwick JM. Iatrogenic delusional parasitosis: a case of physician-patient folie a deux. Gen Hosp Psychiatry. 2010 Mar-Apr. 32(2):210-2. [Medline].

  23. Thakkar A, Ooi KG, Assaad N, Coroneo M. Delusional infestation: are you being bugged?. Clin Ophthalmol. 2015 Jun. 2;9:967-70. [Medline].

  24. Gassiep I, Griffin PM. Delusions of disseminated fungosis. Case Rep Infect Dis. 2014. 2014:458028. [Medline].

  25. Koo J, Lee CS. Delusions of parasitosis. A dermatologist's guide to diagnosis and treatment. Am J Clin Dermatol. 2001. 2(5):285-90. [Medline].

  26. Swick BL, Walling HW. Drug-induced delusions of parasitosis during treatment of Parkinson's disease. J Am Acad Dermatol. 2005 Dec. 53(6):1086-7. [Medline].

  27. Lopez PR, Rachael T, Leicht S, Smalligan RD. Gabapentin-induced delusions of parasitosis. South Med J. 2010. 103:711-2. [Medline].

  28. Steinert T, Studemund H. Acute delusional parasitosis under treatment with ciprofloxacin. Pharmacopsychiatry. 2006 Jul. 39(4):159-60. [Medline].

  29. Tran TM, Browning J, Dell ML. Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report. Malar J. 2006 Aug 23. 5:74. [Medline].

  30. Krauseneck T, Soyka M. Delusional parasitosis associated with pemoline. Psychopathology. 2005 Mar-Apr. 38(2):103-4. [Medline].

  31. Guarneri F, Guarneri C, Mento G, Ioli A. Pseudo-delusory syndrome caused by Limothrips cerealium. Int J Dermatol. 2006 Mar. 45(3):197-9. [Medline].

  32. Ghaffari-Nejad A, Toofani K. Delusion of oral parasitosis in a patient with major depressive disorder. Arch Iran Med. 2006 Jan. 9(1):76-7. [Medline].

  33. Duggal H, Singh I. Delusional parasitosis as a presenting feature of dementia. J Neuropsychiatry Clin Neurosci. 2010 Winter. 22(1):123.E11-12. [Medline].

  34. Trager MJ, Hwang TN, McCulley TJ. Delusions of parasitosis of the eyelids. Ophthal Plast Reconstr Surg. 2008 Jul-Aug. 24(4):317-9. [Medline].

  35. Huber M, Karner M, Kirchler E, Lepping P, Freudenmann RW. Striatal lesions in delusional parasitosis revealed by magnetic resonance imaging. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12. 32(8):1967-71. [Medline].

  36. Hylwa SA, Bury JE, Davis MD, Pittelkow M, Bostwick JM. Delusional Infestation, Including Delusions of Parasitosis: Results of Histologic Examination of Skin Biopsy and Patient-Provided Skin Specimens. Arch Dermatol. May 2011. [Medline].

  37. Patel V, Koo JY. Delusions of Parasitosis; Suggested Dialogue between Dermatologist and Patient. J Dermatolog Treat. 2014 Dec 9. 1-15. [Medline].

  38. Söderfeldt Y, Groß D. Information, consent and treatment of patients with morgellons disease: an ethical perspective. Am J Clin Dermatol. 2014 Apr. 15(2):71-6. [Medline].

  39. Scheinfeld N. Delusions of parasitiosis: a case with a review of its course and treatment. Skinmed. 2003 Nov-Dec. 2(6):376-8. [Medline].

  40. Wenning MT, Davy LE, Catalano G, Catalano MC. Atypical antipsychotics in the treatment of delusional parasitosis. Ann Clin Psychiatry. 2003 Sep-Dec. 15(3-4):233-9. [Medline].

  41. Reichenberg JS, Magid M, Drage LA. A cure for delusions of parasitosis. J Eur Acad Dermatol Venereol. 2007 Nov. 21(10):1423-4. [Medline].

  42. Rocha FL, Hara C. Aripiprazole in delusional parasitosis: Case report. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13. 31(3):784-6. [Medline].

  43. Ladizinski B, Busse KL, Bhutani T, Koo JY. Aripiprazole as a viable alternative for treating delusions of parasitosis. J Drugs Dermatol. Dec 2010. 9:1531-2. [Medline].

  44. Szepietowski JC, Salomon J, Hrehorow E, Pacan P, Zalewska A, Sysa-Jedrzejowska A. Delusional parasitosis in dermatological practice. J Eur Acad Dermatol Venereol. 2007 Apr. 21(4):462-5. [Medline].

  45. Elmer KB, George RM, Peterson K. Therapeutic update: use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis. J Am Acad Dermatol. 2000 Oct. 43(4):683-6. [Medline].

  46. Friedmann AC, Ekeowa-Anderson A, Taylor R, Bewley A. Delusional parasitosis presenting as folie à trois: successful treatment with risperidone. Br J Dermatol. 2006 Oct. 155(4):841-2. [Medline].

  47. Meehan WJ, Badreshia S, Mackley CL. Successful treatment of delusions of parasitosis with olanzapine. Arch Dermatol. 2006 Mar. 142(3):352-5. [Medline].

  48. Freudenmann RW, Schönfeldt-Lecuona C. Delusional parasitosis: treatment with atypical antipsychotics. Ann Acad Med Singapore. 2005 Jan. 34(1):141-2; author reply 142. [Medline].

  49. Atilganoglu U, Ugurad I, Arikan M, Ergun SS. Monosymptomatic hypochondriacal psychosis presenting with recurrent oral mucosal ulcers and multiple skin lesions responding to olanzapine treatment. Int J Dermatol. 2006 Oct. 45(10):1189-92. [Medline].

  50. van Vloten WA. Pimozide: use in dermatology. Dermatol Online J. 2003 Mar. 9(2):3. [Medline].

  51. Fellner MJ, Majeed MH. Tales of bugs, delusions of parasitosis, and what to do. Clin Dermatol. 2009 Jan-Feb. 27(1):135-8. [Medline].

  52. Bennassar A, Guilabert A, Alsina M, Pintor L, Mascaro JM Jr. Treatment of delusional parasitosis with aripiprazole. Arch Dermatol. 2009 Apr. 145(4):500-1. [Medline].

  53. Lim GC, Chen YF, Liu L, Huang SC, Lin KK, Hsiao CH. Camphor-related self-inflicted keratoconjunctivitis complicating delusions of parasitosis. Cornea. 2006 Dec. 25(10):1254-6. [Medline].

  54. Gee SN, Zakhary L, Keuthen N, Kroshinsky D, Kimball AB. A survey assessment of the recognition and treatment of psychocutaneous disorders in the outpatient dermatology setting: how prepared are we?. J Am Acad Dermatol. 2013 Jan. 68(1):47-52. [Medline].

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.